|
A research team from a private research university in Pohang, South Korea, has developed technology that allows diagnosis of diabetes and treatment
The American Diabetes Association (ADA) released a new set of clinical standards that for the first time include the use of autonomous artificial
The American Diabetes Association (ADA) today announced a new collaboration with VSP® Vision Care, a VSP Global® company which serves nearly 90
High blood sugar levels can damage all parts of your body. In this post, we’ll guide you through all the parts of your body, head to toe that
Patients in Australia with diabetes-induced eye disease now have a new treatment option. The Australian Therapeutic Goods Administration (TGS) has
Regeneron Pharmaceuticals, Inc. announced yesterday that the U.S. Food and Drug Administration (FDA) has approved EYLEA® (aflibercept) Injection to
Verseon, a drug discovery company, presented promising preclinical study data for a new, oral diabetic eye drug that could lead to the first real
Mother Nature could have the answer to treating several causes of blindness, according to a ground-breaking study involving scientists from the
Aerpio Pharmaceuticals, a company focused on developing drugs to treat ocular diseases and diabetic complications, today announced top-line results
More Americans with diabetes are now having their eyes checked for a leading cause of blindness using artificial intelligence. IDx-DR, an FDA-cleared
Get a little dLife delivered to your inbox every week.
Leave this field empty if you’re human: